Pharmaceuticals
Healthcare
Top PE firms eye ChrysCapital's stake in Intas Pharma
Several private equity investors are in the fray for PE firm ChrysCapital Investment Advisors Pvt. Ltd’s stake in Intas Pharmaceuticals ......
Healthcare
TA Associates backs pharma products supplier Ideal Cures
Private equity firm TA Associates said on Tuesday it has invested in Mumbai-based Ideal Cures Pvt. Ltd, its second bet ......
Healthcare
Torrent Pharma buying select products of Novartis in India
Ahmedabad-based drugmaker Torrent Pharmaceuticals Ltd has agreed to acquire some of the products of global healthcare company Novartis in India, ......
Healthcare
Delhi HC restrains former Ranbaxy promoters to dilute or sell assets
The Delhi High Court, on Monday, directed former promoters of Ranbaxy Laboratories Ltd, Malvinder Mohan Singh and Shivinder Mohan Singh, ......
Healthcare
Cipla to sell South African animal health business for $29 mn
Mumbai-headquartered pharmaceutical major Cipla Ltd has agreed to sell its animal health business in South Africa to Ascendis Health Ltd ......
Healthcare
Century Pharma hires banker for fresh fundraise; existing investor to exit
Drugmaker Century Pharmaceuticals Ltd has hired an investment bank as it seeks to raise fresh funds and give a full ......
Healthcare
Cipla hires former Dr. Reddy's exec as general counsel
Mumbai-based generic drugmaker Cipla Ltd has hired a former executive at Dr Reddy’s Laboratories Ltd as its global general counsel ......
Healthcare
IFC to make $47.5 mn debt investment in Granules India
International Finance Corporation, the private-sector arm of the World Bank, is planning to provide $47.5 million (Rs 318 crore) in ......
Healthcare
Eris Lifesciences files DRHP for IPO; ChrysCap to exit
Ahmedabad-based pharmaceutical firm Eris Lifesciences Pvt. Ltd filed a draft red herring prospectus with the capital markets regulator Securities and ......
Healthcare
Aurobindo Pharma buys four biosimilar drugs from TL Biopharmaceutical
Drugmaker Aurobindo Pharma Ltd has bought four biosimilar products from Swiss firm TL Biopharmaceutical AG, marking its entry into the ......